Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Child & Adolescent Psychiatry

01-08-2004 | ORIGINAL CONTRIBUTION

A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD

Authors: Jan K. Buitelaar, M. D., Ph. D., Marina Danckaerts, Christopher Gillberg, Alessandro Zuddas, Katja Becker, Manuel Bouvard, Jenny Fagan, Julia Gadoros, Valerie Harpin, Philip Hazell, Mats Johnson, Tally Lerman-Sagie, Cesar A. Soutullo, Tomasz Wolanczyk, Pal Zeiner, Daniel S. Fouche, Judith Krikke-Workel, Shuyu Zhang, David Michelson, for the Atomoxetine International Study Group

Published in: European Child & Adolescent Psychiatry | Issue 4/2004

Login to get access
Metadata
Title
A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD
Authors
Jan K. Buitelaar, M. D., Ph. D.
Marina Danckaerts
Christopher Gillberg
Alessandro Zuddas
Katja Becker
Manuel Bouvard
Jenny Fagan
Julia Gadoros
Valerie Harpin
Philip Hazell
Mats Johnson
Tally Lerman-Sagie
Cesar A. Soutullo
Tomasz Wolanczyk
Pal Zeiner
Daniel S. Fouche
Judith Krikke-Workel
Shuyu Zhang
David Michelson
for the Atomoxetine International Study Group
Publication date
01-08-2004
Publisher
Steinkopff-Verlag
Published in
European Child & Adolescent Psychiatry / Issue 4/2004
Print ISSN: 1018-8827
Electronic ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-004-0401-3